Fundz

Mereo Biopharma Group Plc reported raising $70 Million in an initial SEC Form D filing, from an offering of $70 Million

PUBLIC · MREOJun 12, 2020

Amount Raised

$70 Million

$70 Million sold, per SEC Form D (first sale Jun 12, 2020)

Round Type

Venture

United KingdomBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

Mereo Biopharma Group plc raised $70 Million in a funding round, dated June 12, 2020. Mereo Biopharma Group plc is based in United Kingdom.

How much did Mereo Biopharma Group plc raise?
Mereo Biopharma Group plc raised $70 Million in a funding round on June 12, 2020.
What does Mereo Biopharma Group plc do?
Mereo Biopharma Group PLC is a biopharmaceutical company focused on developing innovative medicines for patients with unmet medical needs.
Where is Mereo Biopharma Group plc based and how big is it?
Mereo Biopharma Group plc is based in United Kingdom.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Mereo Biopharma Group plc that raised within 45 days of this round, from Fundz verified event records.

Who to call at Mereo Biopharma Group plc, and when

A new round usually means Mereo Biopharma Group plc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mereo Biopharma Group plc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mereo Biopharma Group plc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mereo Biopharma Group plc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mereo Biopharma Group plc

Location

1 CAVENDISH PLACE

United Kingdom

About

Mereo Biopharma Group PLC is a biopharmaceutical company focused on developing innovative medicines for patients with unmet medical needs. The company aims to deliver transformative therapies tailored to address rare diseases and underserved patient populations. Mereo’s pipeline includes various programs targeting different therapeutic areas. The company is headquartered in London, United Kingdom.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mereo Biopharma Group plc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mereo Biopharma Group plc's next move

See what Strategic adds

Mereo Biopharma Group plc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.